🧵We are delighted to be working with organisations to improve the outlook for paediatric prescribing of CBPMs.
💡The Alliance for Paediatric Prescribing has been formed to create a clinical community to feel supported and informed on prescribing CBPMs for children with epilepsy
A study on paediatric #ASD in @Transl_Psych reported significant improvements in social communication abilities after six months treatment with cannabidiol-rich cannabis oil, and a reduction in restrictive and repetitive behaviors of children with #autism
https://t.co/7rGwmNgiE6
The Script Assist platform guides clinicians through every stage of required governance for prescribing medical cannabis and risk management measures, while giving doctors practical tools for issuing prescriptions and tracking patient symptoms in real time with the paired app.
At Sana, we’ve been working since the start to solve the problems faced by doctors, private practices and patients when it comes to prescribing medical cannabis.
Today, we’re proud to share our solution: Script Assist
If medical cannabis is to become mainstream, clinicians' confidence to prescribe must be addressed.
@Medscape spoke to our clinical advisor Dr Mark Smith, a cannabis prescriber in the UK about current barriers in the system for patients and prescribers: https://t.co/kgJz0YNhLf
Clinicians want to prescribe cannabis treatments that are supported by safety and efficacy data.
Our partnership with @canndirectory is bringing cannabis prescribing in line with other treatments and prescribing methods freely available to UK doctors: https://t.co/WTrRQE4bP4
Thank you to @PLEA_community and to our fellow panelists for a great exchange of ideas about medical cannabis research and paediatric epilepsy last night at #MCAW2022
"There are research initiatives that manufacturers could be taking advantage of and aren't... there is more they could be doing to provide the evidence that clinical communities are calling for and they are doing a disservice to patients by not doing that" - Hannah Simon
We're glad to be joining this panel to discuss such an important issue for medical cannabis patients in the UK.
Register for free for this event here: https://t.co/WGAgv3oLaV
New study from researchers @HopkinsMedicine: 77% of patients with neurological and pain-related conditions using medical cannabis reported positive effects, including reduced pain, improved sleep and reduced anxiety. https://t.co/lOwlQCBm0Y
New study published in @ArthroToday: Researchers found that patients in Colorado who self-report consuming cannabis following hip or knee surgery are less likely than non-users to engage in the long-term use of prescription opioids:
https://t.co/7ry7RyD6yk
It is so important for UK healthcare pros to learn about cannabis medicines, especially ones UK patients might not have access to yet, so patients can access the medicines that will best help their conditions ❤️
Great to hear this news @Sana_Healthcare 👏 https://t.co/EgLJQrU5LP
New Study: Australian youth mental health organization @orygen_aus found that teens and young adults with treatment-resistant anxiety who were given a single daily CBD pill for 12 weeks reported their symptoms fell by ~43% https://t.co/qmRu62AK3G
Interesting findings from @MassGenBrigham: As legal #medicalcannabis becomes increasingly available, individuals are using it as an adjunct treatment for menopause related symptoms via a variety of different modes of use. https://t.co/qX0FEk7sll https://t.co/rTh1TpYbjP
Thank you to @ToniaAntoniazzi for raising this serious issue again for many suffering families. NHS funded access is the only solution. @sajidjavid I believed you when you told me you would help everyone. Come on, they have waited four years. Time to act. #Westandwithyou
“A dead child is not better than a child on cannabis. This is not acceptable.”
A heartfelt thank you to Dr Bonni Goldstein, I was honoured to speak with you today at #CannabisEuropa and I'm so thankful for all the doctors like you sticking up for children and families like mine.
Both anecdotal evidence and growing research indicate that cannabis may reduce symptoms of PTSD.
Unfortunately, legal restrictions on access have limited scientific evaluation of #medicalcannabis for treatment of disorders like PTSD. #PTSDAwarenessDay https://t.co/1nrLOTT3i3
New research on Canadian medical cannabis patients found that 47% of respondents substituted cannabis for other controlled substances.
Of those who said that they used cannabis in place of prescription medications, half acknowledged doing so for opioids:
https://t.co/2hoBaWlB2S
Understanding the endocannabinoid system is key for healthcare professionals understanding how and why medical cannabis works, and how we can continue to advance cannabis medicines.
This is a great resource by @Peter_Grinspoon for @HarvardHealth : https://t.co/i25eZVFEW1